Healthy Sleepers F51.0
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: • Age 30 to 60 years (a limited age range seems adequate in order to avoid marked age-related confounds) • For the patient group: ID diagnosis (DSM 5, APA, 2013) and a mismatch between subjective and objective total sleep time of at least 60 minutes (i.e. in the direction of a subjective underestimation of TST). Subjective TST will be derived from the 14 day sleep diary and will be contrasted to the PSG derived TST of the baseline night. • Normal hearing (as determined by audiometry) • Signed informed consent
Exclusion criteria
Exclusion criteria: • Psychiatric diseases (acute/ lifetime) in the control group (evaluated with the SCID-I) • Other acute and lifetime psychiatric diseases apart from Insomnia Disorder in the patient group (evaluated with the SCID-I) • Sleep disorders according to the International Classification of Sleep Disorders (ICSD-3; AASM, 2013) in the control group (evaluated by a clinical interview and a polysomnographic investigation in the sleep laboratory of the Department of Psychiatry and Psychotherapy) • Other sleep disorders apart from primary insomnia according to the International Classification of Sleep Disorders (ICSD-3; AASM, 2013) in the patient group (evaluated by a clinical interview and a polysomnographic investigation in the sleep laboratory of the Centre for Mental Disorders - see also description of sleep recordings for details) • Shift work or transmeridian flights within the last 4 weeks and irregular sleep-wake rhythms (frequent shifts of bedtimes > 1 hour) • Regular intake of any psychotropic substance known to affect sleep within the two weeks before the investigation or during the participation in this study; or ongoing psychotherapy • Pregnancy or lactation • Clinically significant, severe or unstable medical diseases that have an impact on sleep
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| P2 amplitude as measured with event related potentials | — |
Secondary
| Measure | Time frame |
|---|---|
| N1 amplitude as measured with event-related potentials | — |
Countries
Germany
Contacts
Abteilung für Klinische Psycholgie und PsychophysiologieKlinik für Psychiatrie und PsychotherapieUniversitätsklinik Freiburg